Keystone Symposia

This meeting took place in 2022



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

A Research Reboot of Tuberculosis on the Keystone Symposia 50th Anniversary - RESCHEDULED (RA3)


Organizer(s) Joseph Keane, Shabaana A. Khader, Thomas J. Scriba and Alan Sher
August 1—4, 2022
Beaver Run Conference Center • Breckenridge, CO USA
Abstract Deadline: May 19, 2022
Scholarship Deadline: Oct 21, 2021
Discounted Registration Deadline: Jun 1, 2022

Supported by the Directors' Fund

Summary of Meeting:
Tuberculosis is an ancient scourge of mankind that today remains a leading cause of death by a single infectious agent only surpassed in its global mortality by the current COVID-19 coronavirus pandemic. Nevertheless, with the advent of effective antibiotics and improved public health measures, TB in the middle of the 20th century had substantially declined and was thought by many to be destined for eradication. By 1972, the year of the founding of the Keystone Symposia, this conclusion was quashed by expanding caseloads in New York City and other urban areas and later by the devastating impact of HIV-coinfection. This major disease re-emergence stimulated a new era of intense research aimed at conquering TB. In this symposium, we will use the occasion of the Keystone Symposium 50th Anniversary celebration, to showcase the outstanding breakthroughs of TB researchers in the 50 years since the Keystone founding while highlighting current advances. Because of their current promise, special attention will be given to the results of recent vaccine trials as well the discovery and implementation of improved antibiotic regimens. Also emphasized will be exciting advances in our basic understanding of the host-pathogen interaction, and in particular in the area of immunometabolism, that are leading to the identification of new host-directed treatment targets. Keynote lectures will overview the major achievements of the past 50 years, the current state of global tuberculosis as well as the impact of viral pandemics on tuberculosis research and control and on the achievement of our ultimate goal of TB eradication.

View Meeting Program

Scholarships/Awards


Burroughs Wellcome Fund Scholarship Recipients


Steven J. Grigsby
Washington University School of Medicine, USA

Bianca A. Lepe
MIT, USA

Jessica Marie Medrano
University of Pittsburgh School of Medicine, USA

Harley Parker
Johns Hopkins University, USA

Cheung Family Charitable Giving Fund Scholarship Recipients


Komal Chauhan
ICGEB New Delhi, India

Saiyukthi Naidoo
University of Cape Town, South Africa

Michaela Reichmann
University of Southampton, UK

Dylan Sheerin
WEHI, Australia

Diogo Fonseca Silvério
ICBAS, Portugal

National Institute of Allergy and Infectious Diseases (NIAID) Scholarship Recipients


Lauren M. Cross
Seattle Children's Research Institute, USA

Skyler Hendrix
Washington University in St. Louis, USA

Eva Kaufmann
McGill University, Canada

Erica C. Larson
University of Pittsburgh, USA

Jees Sebastian
Rutgers New Jersey Medical School, USA

Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation


Gift Ahimbisibwe
MRC/UVRI&LSHTM,Uganda Research Unit, Uganda

Prince Asare
Noguchi Memorial Institute for Medical Research, Ghana

Fabiana Bigi
Institute of Biotechnology, Argentina

One Bridget Dintwe
Cape Town HVTN Immunology Laboratory, South Africa

Delfina Ensinck
Institute of Molecular and Celullar Biology or Rosario-Conicet, National Univers, Argentina

Belen Rocio Imperiale
IMEX-CONICET-National Academy of Medicine, Argentina

Nishank Mehta
All India Institute of Medical Sciences, New Delhi, India

Nathella Pavan Kumar
National Institute for Research in Tuberculosis, India

Maria Florencia Quiroga
University of Buenos Aires School of Medicine, Argentina

Cristina Lourdes Vázquez
Instituto Nacional de Tecnologías Agropecuarias, Argentina